COMPASS Pathways Ownership | Who Owns COMPASS Pathways?
COMPASS Pathways Ownership Summary
COMPASS Pathways is owned by 27.45% institutional investors, 12.12% insiders, and 60.43% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 9.33% of CMPS shares. ARK Genomic Revolution ETF is the top mutual fund, with 2.54% of its assets in COMPASS Pathways shares.
CMPS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | COMPASS Pathways | 27.45% | 12.12% | 60.43% |
| Sector | Healthcare Stocks | 232.20% | 10.74% | -142.94% |
| Industry | Medical Care Facilities Stocks | 33.52% | 12.46% | 54.02% |
| Idea | Psychedelic Stocks List | 20.20% | 9.72% | 70.08% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Rtw investments, lp | 8.71M | 9.33% | $49.89M |
| Deep track capital, lp | 7.86M | 8.42% | $45.04M |
| Millennium management | 3.41M | 4.99% | $12.90M |
| Gmt capital | 2.84M | 3.05% | $16.30M |
| Tang capital management | 2.20M | 2.36% | $12.61M |
| Ark investment management | 2.16M | 2.26% | $14.88M |
| Ubs group | 2.04M | 2.14% | $14.07M |
| Pfm health sciences, lp | 1.66M | 1.78% | $9.53M |
| Jefferies financial group | 1.58M | 1.65% | $10.88M |
| Eagle health investments lp | 1.52M | 1.59% | $10.48M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Founders fund vii management | 278.88K | 93.02% | $1.60M |
| Propel bio management | 861.78K | 5.08% | $5.95M |
| Ally bridge group (ny) | 1.03M | 3.58% | $5.88M |
| Eagle health investments lp | 1.52M | 2.30% | $10.48M |
| Lion point capital, lp | 58.00K | 1.89% | $332.34K |
| Aisling capital management lp | 1.20M | 1.73% | $8.27M |
| Deep track capital, lp | 7.86M | 1.26% | $45.04M |
| Dafna capital management | 811.05K | 1.15% | $4.65M |
| Brown university | 214.20K | 1.04% | $1.48M |
| Gmt capital | 2.84M | 0.74% | $16.30M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ameriprise financial | 1.21M | 0.00% | 1.21M |
| Gmt capital | 2.84M | 0.74% | 1.06M |
| Two sigma investments, lp | 1.08M | 0.01% | 960.68K |
| Tang capital management | 2.20M | 0.49% | 900.00K |
| Eagle health investments lp | 1.52M | 2.30% | 583.94K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tcg crossover management | - | - | -3.86M |
| Vivo capital | - | - | -3.36M |
| Laurion capital management lp | - | - | -1.76M |
| Woodline partners lp | - | - | -1.76M |
| Altium capital management lp | - | - | -1.42M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ameriprise financial | 1.21M | 0.00% | 1.21M | $6.93B |
| Stempoint capital lp | 275.62K | 0.32% | 275.62K | $1.58M |
| Ecor1 capital | 265.14K | 0.07% | 265.14K | $1.52M |
| Legal & general group | 218.41K | 0.00% | 218.41K | $1.51M |
| Affinity asset advisors | 200.00K | 0.10% | 200.00K | $1.15M |
Sold Out
| Holder | Change |
|---|---|
| American capital advisory | -5.00 |
| Corecap advisors | -10.00 |
| Nelson, van denburg & campbell wealth management group | -15.00 |
| Jamison private wealth management | -20.00 |
| Strategic wealth investment group | -20.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 116 | -33.33% | 26,166,617 | -52.83% | 27 | 0.78% | 40 | -55.56% | 31 | 24.00% |
| Sep 30, 2025 | 166 | 12.93% | 55,434,535 | 8.93% | 59 | 2.00% | 87 | 42.62% | 25 | -30.56% |
| Jun 30, 2025 | 150 | 7.14% | 51,720,681 | 3.71% | 55 | 1.77% | 61 | -1.61% | 38 | 40.74% |
| Mar 31, 2025 | 142 | 5.19% | 51,907,706 | 67.77% | 58 | 2.84% | 64 | 8.47% | 26 | - |
| Dec 31, 2024 | 114 | -17.99% | 18,014,918 | -45.03% | 26 | 1.15% | 52 | - | 21 | -19.23% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Genomic Revolution ETF | 2.89M | 2.54% | - |
| ARK Genomic Revolution | 2.06M | 1.82% | 7.69K |
| HSBC GIF Glb Eq Sust Hlthcare AC USD | 1.46M | 1.29% | 154.53K |
| International Biotechnology Ord | 570.46K | 0.50% | - |
| iShares Biotechnology ETF | 532.58K | 0.47% | 144.79K |
| Nikko Gbl All Biological Genome Eq MF | 316.75K | 0.46% | -67.45K |
| Columbia Small Cap Value I A | 392.51K | 0.41% | 392.51K |
| Columbia Small Cap Value Discv A | 406.21K | 0.36% | 406.21K |
| Columbia Small Cap Value Discovery Fund | 402.01K | 0.35% | 9.50K |
| TEQ - Disruptive Technologies - I-II | 378.71K | 0.33% | 25.71K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 24, 2024 | Malievskaia Ekaterina | - | Sell | - |
| Oct 24, 2024 | Malievskaia Ekaterina | - | Sell | - |
| Oct 24, 2024 | Goldsmith George Jay | - | Sell | - |
| Oct 24, 2024 | Goldsmith George Jay | - | Sell | - |
| Sep 26, 2024 | ATAI Life Sciences N.V. | - | Sell | $16.09M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
CMPS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools